Cancéropôle Est
- Company typePrivate
- Founded2003
- HeadquartersStrasbourg, France
- Headcount—
- GTM typeB2B
- OfferingServices
Cancéropôle Est firmographics
Firmographics- Name
- Cancéropôle Est
- Legal name
- Cancéropôle Est
- Website
- https://canceropole-est.org
- Company type
- Private
- Founded year
- 2003
- Operating status
- Operating
- Ownership category
- akta.pro rank
Cancéropôle Est industry classification
Industry- Product category
- Cancer Research Coordination Services
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Health Research Funding Agencies (Public/Quasi-Public) (HLAJALAB)
- akta.pro secondary industry
- Medical Oncology (HLAKAFAB)
Keywords
Where Cancéropôle Est is headquartered
LocationHeadquarters
- HQ city
- Strasbourg
- HQ country
- France
- HQ region
- Europe
Offices6 records
Markets served
Cancéropôle Est business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Public funding and institutional support: As an association under local law (loi 1908) presided by regional presidents, Cancéropôle Est receives funding from public sources including INCa (Institut National du Cancer) through contractual objectives and performance agreements (Contrat d'Objectifs et de Performance 2023-2027), regional governments, and potentially foundation support from Ligue contre le Cancer and Fondation ARC
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
Cancéropôle Est product offering
Product offeringCore offering
Cancéropôle Est is a non-profit cancer research coordination association that structures, animates, and funds collaborative cancer research across the Grand Est and Bourgogne-Franche-Comté regions. It operates five thematic research networks (Parcours de santé, Lésions prénéoplasiques, RIBIOTHIM-Onco, Biopsies liquides, Pancréas-CGE), runs an Emergence funding program, maintains the eSCAPE researcher platform, and organizes scientific forums, training, and cross-border collaborations with neighboring European countries.
Product overview
Cancéropôle Est is a cancer research coordination organization (association loi 1908) supporting innovative research across the Grand Est and Bourgogne-Franche-Comté regions of France. Rather than a commercial product company, it provides a portfolio of research networks, funding programs, training resources, and scientific events. Its core offerings include five thematic research networks (Parcours de santé, Lésions prénéoplasiques, RIBIOTHIM-Onco, Biopsies liquides, and Pancréas-CGE project), the eSCAPE platform for researchers, the Emergence funding programs for innovative projects, scientific training including the MOOC NGS & CANCER, and annual forums/conferences such as the Forum du Cancéropôle Est and international conferences on nanomedicine and innovative therapies.
Differentiator
Problem solved
Functional benefit
Products and services
- Réseau Parcours de santé Thematic research network on healthcare pathways, Human and Social Sciences, Epidemiology and Public Health in oncology, covering prevention, screening, patient support during care, and quality of life; aimed at researchers and clinicians in the interregion.
- Réseau Lésions prénéoplasiques Research network studying the mechanisms of pre-neoplastic lesion progression and regression, with the goal of identifying biomarkers and risk factors for early detection and interception before lesions progress to cancer; aimed at researchers and clinicians in the interregion.
- Réseau RIBIOTHIM-Onco Research network on ionizing radiations in biology, combined therapies and molecular imaging, covering external radiotherapy, vectorized internal radiotherapy, radio-sensitizing nanoparticles, and combinations with immunotherapy; aimed at researchers and clinicians in the interregion.
- Réseau Biopsies liquides Research network dedicated to liquid biopsy research for cancer diagnosis and monitoring through analysis of biological fluids; aimed at researchers and clinicians in the interregion.
- Projet Pancréas-CGE
Companies that use Cancéropôle Est
Customer profileNamed customers15 records
Segments4 records
Ideal customer profiles3 records
Cancéropôle Est technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Cancéropôle Est partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered core and minor.
- INCa (Institut National du Cancer)coreFrench National Cancer Institute - national coordination body with which Cancéropôle Est has a Contrat d'Objectifs et de Performance (2023-2027) defining missions and objectives
- CHU NancycoreRegional university hospital center partner providing clinical research capacity
- CHR Metz-ThionvillecoreRegional hospital center partner providing clinical research capacity
- Institut Strauss (Strasbourg)coreOne of 4 cancer centers in the network, providing specialized oncology research and care
- Université de StrasbourgcoreOne of the 5 partner universities in the Cancéropôle Est network, contributing researchers and academic resources to coordinated cancer research efforts across the interregion
- Université de BourgognecoreOne of the 5 partner universities in the Cancéropôle Est network
- Université de Reims Champagne-ArdennecoreOne of the 5 partner universities in the Cancéropôle Est network
- Université de Franche-ComtécoreOne of the 5 partner universities in the Cancéropôle Est network
- Université de LorrainecoreOne of the 5 partner universities in the Cancéropôle Est network
- CHU StrasbourgcoreRegional university hospital center partner providing clinical research capacity
- CHU DijoncoreRegional university hospital center partner providing clinical research capacity
- CHU ReimscoreRegional university hospital center partner providing clinical research capacity
- CHU BesançoncoreRegional university hospital center partner providing clinical research capacity
- Centre Georges-François Leclerc (Dijon)coreOne of 4 cancer centers in the network, providing specialized oncology research and care
- Institut Jean Godinot (Reims)coreOne of 4 cancer centers in the network, providing specialized oncology research and care
- Institut de Cancérologie de Lorraine (Nancy)coreOne of 4 cancer centers in the network, providing specialized oncology research and care
- INSERMcoreFrench National Institute of Health and Medical Research - major national research organization partner providing scientific expertise and research capacity
- CNRScoreFrench National Centre for Scientific Research - major national research organization partner providing scientific expertise and research capacity
- INRIAcoreFrench National Institute for Research in Computer Science and Automation - national research organization partner contributing computational and digital research expertise
- Ligue nationale contre le CancerminorNational cancer league represented in the Board of Directors, providing funding support through grants and scholarships
- Fondation ARCminorCancer research foundation represented in the Board of Directors, providing funding support for research projects
- Cross-border partners (Germany, Belgium, Luxembourg, Switzerland)minorProximity with European neighbors encourages cross-border dynamics on specific projects, including organization of symposiums, workshops, cross-border project calls (Emergence Transfrontalier), and mobility grants for young researchers
Scale indicators6 records
Cancéropôle Est competitors and assessment
Company assessmentDirect peers
- Cancéropôle CLARA: Canceropôle Lyon Auvergne-Rhône-Alpes — sister Cancéropôle under the same French Cancer Plan 2003 architecture, performing the same cancer research coordination role across a different French interregion. Most structurally comparable peer.
- Cancéropôle Île-de-France: Paris-region Cancéropôle coordinating oncology research across Île-de-France's universities, AP-HP hospitals, and cancer centers under the same national framework as Cancéropôle Est.
- Cancéropôle Grand Ouest: Western France Cancéropôle (Brittany, Pays de la Loire, Normandy) coordinating oncology research networks, calls for projects, and clinical translation — direct institutional peer with identical mission.
- Cancéropôle Nord-Ouest: Northern France Cancéropôle coordinating cancer research across Hauts-de-France and other northern territories; same governance model under INCa performance contracts.
- Cancéropôle Sud-Méditerranée (PACA): Provence-Alpes-Côte d'Azur Cancéropôle coordinating oncology research in southern France; identical cancer-research coordination mandate and INCa contractual framework.
- Cancéropôle Grand Sud-Ouest (Occitanie): Southwestern France Cancéropôle (Toulouse, Occitanie) coordinating cancer research with the same national Cancer Plan governance as Cancéropôle Est.
Broad incumbents
- INCa (Institut National du Cancer): French national cancer agency that funds and contracts with all seven Cancéropôles. Operates at the national level as the umbrella counterpart and primary funder of Cancéropôle Est.
- EORTC (European Organisation for Research and Treatment of Cancer): European-level oncology research coordination organization running multi-country clinical trials and translational research programs; broader international equivalent of the Cancéropôle model.
- Cancer Research UK: Largest cancer research charity coordinating and funding UK oncology research across universities and hospitals; comparable as a multi-institutional research-funding and coordination body, though operating at much larger scale.
Others
- DGOS (Direction Générale de l'Offre de Soins): French directorate within the Ministry of Health that funds hospital-based research (PHRC, PHRIP) and overlaps with Cancéropôle Est's clinical research coordination role in public-sector oncology.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Cancéropôle Est social profiles
Digital presenceCancéropôle Est financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cancéropôle Est leadership team
Management profileNumber of profiles
Profiles8 records
Cancéropôle Est funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cancéropôle Est M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cancéropôle Est
What does Cancéropôle Est do?
Cancéropôle Est is a non-profit cancer research coordination association that structures, animates, and funds collaborative cancer research across the Grand Est and Bourgogne-Franche-Comté regions. It operates five thematic research networks (Parcours de santé, Lésions prénéoplasiques, RIBIOTHIM-Onco, Biopsies liquides, Pancréas-CGE), runs an Emergence funding program, maintains the eSCAPE researcher platform, and organizes scientific forums, training, and cross-border collaborations with neighboring European countries.
Is Cancéropôle Est a public or private company?
Cancéropôle Est is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Cancéropôle Est founded?
Cancéropôle Est was founded in 2003.
Where is Cancéropôle Est based?
Cancéropôle Est is headquartered in Strasbourg, France, in the Europe region.
How does Cancéropôle Est make money?
One revenue line is on record: public funding and institutional support.
Who are Cancéropôle Est's main competitors?
Direct peers on record are Cancéropôle CLARA, Cancéropôle Île-de-France, Cancéropôle Grand Ouest, Cancéropôle Nord-Ouest, Cancéropôle Sud-Méditerranée (PACA) and Cancéropôle Grand Sud-Ouest (Occitanie). Broad incumbents are INCa (Institut National du Cancer), EORTC (European Organisation for Research and Treatment of Cancer) and Cancer Research UK. DGOS (Direction Générale de l'Offre de Soins) is listed as an others.
Does Cancéropôle Est have an API?
No public API is recorded for Cancéropôle Est.
What industry is Cancéropôle Est in?
Cancéropôle Est's product category is Cancer Research Coordination Services. Its primary akta.pro industry code is HLAJALAB, Health Research Funding Agencies (Public/Quasi-Public), with a secondary code of HLAKAFAB, Medical Oncology. Its NAICS code is 5417 and its SIC code is 8731.